Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?

Affiliations

¹ Liver Unit, Internal Medicine Department, Vall d'Hebron Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: mar.riveiro@gmail.com.
² Oncology Department, Vall d'Hebron Institut of Oncology (VHIO), Vall d'Hebron Hospital, Barcelona, Spain.
³ Blood Bank, Banc de Sang i Teixits, Vall d'Hebron Hospital, Barcelona, Spain.
⁴ Liver Unit, Internal Medicine Department, Vall d'Hebron Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

Comment

Mar Riveiro-Barciela et al. J Hepatol. 2019 Mar.

. 2019 Mar;70(3):564-566.

doi: 10.1016/j.jhep.2018.10.020. Epub 2018 Nov 28.

¹ Liver Unit, Internal Medicine Department, Vall d'Hebron Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: mar.riveiro@gmail.com.
² Oncology Department, Vall d'Hebron Institut of Oncology (VHIO), Vall d'Hebron Hospital, Barcelona, Spain.
³ Blood Bank, Banc de Sang i Teixits, Vall d'Hebron Hospital, Barcelona, Spain.
⁴ Liver Unit, Internal Medicine Department, Vall d'Hebron Hospital, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.

No abstract available

Keywords: Acute liver failure; Immune-mediated hepatitis; Immunotherapy; Plasma exchange.

Comment in

Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?".
De Martin E, Michot JM, Papouin B, Champiat S, Lambotte O, Robert C, Marabelle A, Guettier C, Samuel D. De Martin E, et al. J Hepatol. 2019 Mar;70(3):566-567. doi: 10.1016/j.jhep.2018.11.016. Epub 2018 Dec 5. J Hepatol. 2019. PMID: 30527952 No abstract available.

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
De Martin E, Michot JM, Papouin B, Champiat S, Mateus C, Lambotte O, Roche B, Antonini TM, Coilly A, Laghouati S, Robert C, Marabelle A, Guettier C, Samuel D. De Martin E, et al. J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8. J Hepatol. 2018. PMID: 29427729